09.17.12
Celerion has been awarded full accreditation by the Association for the Accreditation Human Research Protection Programs (AAHRPP) for its U.S. clinical facilities in Lincoln NE, Neptune NJ, and Phoenix AZ.
AAHRPP is an independent accrediting body that uses a voluntary educational model to ensure that Human Research Protection Programs (HRPPs) meet quality and protection standards. Celerion earned the accreditation having provided evidence—through policies, procedures, and practices—of its commitment to scientifically and ethically sound research and to continuous improvement.
AAHRPP reviewed all internal procedures and processes to ensure extensive safeguards were in place at every level of clinical research and teams were evaluated on their respective areas of responsibility, and reviewed policies, processes, and SOPs.
“The approval of AAHRPP certification continues to demonstrate the leadership role Celerion has taken to reach the highest standards and protections for human participants. By voluntarily undergoing the accreditation process, Celerion has committed to participants in our clinical studies that rigorous standards will be applied to ensure their safety and rights are strictly adhered to,” said Susan Thornton, Ph.D., president and chief executive officer at Celerion. “This accreditation also highlights our commitment to increased quality and transparency in conducting ethically sound research for our clients.”
AAHRPP is an independent accrediting body that uses a voluntary educational model to ensure that Human Research Protection Programs (HRPPs) meet quality and protection standards. Celerion earned the accreditation having provided evidence—through policies, procedures, and practices—of its commitment to scientifically and ethically sound research and to continuous improvement.
AAHRPP reviewed all internal procedures and processes to ensure extensive safeguards were in place at every level of clinical research and teams were evaluated on their respective areas of responsibility, and reviewed policies, processes, and SOPs.
“The approval of AAHRPP certification continues to demonstrate the leadership role Celerion has taken to reach the highest standards and protections for human participants. By voluntarily undergoing the accreditation process, Celerion has committed to participants in our clinical studies that rigorous standards will be applied to ensure their safety and rights are strictly adhered to,” said Susan Thornton, Ph.D., president and chief executive officer at Celerion. “This accreditation also highlights our commitment to increased quality and transparency in conducting ethically sound research for our clients.”